Cantor Fitzgerald’s Chemed CHE Stock Holding History

Cantor Fitzgerald’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-546	Closed	-$296K	–	571
2023 Q2	$296K	Hold	546	–	–	0.01%	444
2023 Q1	$294K	Sell	546 -16	-3%	-$8.16K	0.01%	491
2022 Q4	$287K	Sell	562 -64	-10%	-$31.2K	0.01%	524
2022 Q3	$273K	Sell	626 -4	-0.6%	-$1.92K	0.01%	576
2022 Q2	$296K	Buy	+630	New	+$307K	0.01%	605

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Cantor Fitzgerald's CHE Position: Q3 2023 in Review

Cantor Fitzgerald sold out of Chemed (CHE) in Q3 2023, closing a stake of 546 shares — an estimated $296K sold.

Cantor Fitzgerald first reported a position in CHE in Q2 2022 and held it in 5 quarters. The position peaked at $296K in Q2 2022. 457 funds tracked by Wall St. Rank hold CHE as of Q3 2023.

Cantor Fitzgerald reported no remaining Chemed position as of Q3 2023 after selling out during the quarter.
Cantor Fitzgerald sold 546 Chemed shares in Q3 2023, an estimated $296K.
Cantor Fitzgerald first reported a position in Chemed in Q2 2022 and held it in 5 quarters.
Cantor Fitzgerald's Chemed position peaked at $296K in Q2 2022.
457 funds tracked by Wall St. Rank held Chemed as of Q3 2023.

Based on Cantor Fitzgerald's 13F filing for Q3 2023, filed 14 Nov 2023.